• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[近期从临床标本中分离出的铜绿假单胞菌对各种抗菌剂的敏感性以及对羧苄青霉素、庆大霉素和丁胺卡那霉素敏感性的变化(作者译)]

[Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].

作者信息

Kosakai N, Oguri T

出版信息

Jpn J Antibiot. 1980 Jun;33(6):668-74.

PMID:6779031
Abstract

We estimated the minimum inhibitory concentrations of following twenty-one antimicrobial agents against 161 strains of Pseudomonas aeruginosa isolated from clinical specimens during 1979. Antimicrobial agents were 5 penicillins (carbenicillin, sulbenicillin, piperacillin, apalcillin and ticarcillin), 3 cephalosporins (cefsulodin, cefoperazone and ceftizoxime), 5 aminoglycosides (gentamicin, tobramycin, dibekacin, amikacin and kanamycin), 3 tetracycclines (tetracyline, doxycycline and minocycline), chloramphenicol, colistin, polymyxin B, nalidixic acid and pipemidic acid. Among penicillins piperacillin and apalcillin showed strongest antibacterial activity and the activity of carbenicillin was weakest. Highly resistant strains against carbenicillin increased rapidly until 1975. Among cephalosporins cefsulodin showed strongest antibacterial activity and its activity was stronger than piperacillin. Antibacterial activity of cefoperazone and ceftizoxime were weaker than cefsulodin, but stronger than carbenicillin and sulbenicillin. Among aminoglycosides kanamycin showed very weak antibacterial activity, but another four drugs showed very strong activity. But resistant strains against these four drugs increased gradually and over 20% of strains was resistant to gentamicin. Among gentamicin, tobramycin and dibekacin cross-resistance was observed, but not between amikacin and these three drugs. Recently the number of strains resistant to both amikacin and gentamicin increased. Tetracyclines, chloramphenicol and nalidixic acid showed rather weak activity, but colistin and polymyxin B showed very strong activity and resistant strains against these drugs were very few. Pipemidic acid showed rather stronger activity than nalidixic acid, but its activity was weaker than aminoglycosides excluding kanamycin.

摘要

我们测定了1979年从临床标本中分离出的161株铜绿假单胞菌对以下21种抗菌药物的最低抑菌浓度。抗菌药物包括5种青霉素(羧苄西林、磺苄西林、哌拉西林、阿洛西林和替卡西林)、3种头孢菌素(头孢磺啶、头孢哌酮和头孢唑肟)、5种氨基糖苷类(庆大霉素、妥布霉素、地贝卡星、阿米卡星和卡那霉素)、3种四环素(四环素、多西环素和米诺环素)、氯霉素、黏菌素、多黏菌素B、萘啶酸和吡哌酸。在青霉素中,哌拉西林和阿洛西林显示出最强的抗菌活性,而羧苄西林的活性最弱。对羧苄西林高度耐药的菌株在1975年之前迅速增加。在头孢菌素中,头孢磺啶显示出最强的抗菌活性,其活性强于哌拉西林。头孢哌酮和头孢唑肟的抗菌活性弱于头孢磺啶,但强于羧苄西林和磺苄西林。在氨基糖苷类中,卡那霉素显示出非常弱的抗菌活性,但其他四种药物显示出非常强的活性。但对这四种药物的耐药菌株逐渐增加,超过20%的菌株对庆大霉素耐药。在庆大霉素、妥布霉素和地贝卡星之间观察到交叉耐药,但阿米卡星与这三种药物之间没有交叉耐药。最近,对阿米卡星和庆大霉素均耐药的菌株数量有所增加。四环素、氯霉素和萘啶酸显示出相当弱的活性,但黏菌素和多黏菌素B显示出非常强的活性,对这些药物的耐药菌株很少。吡哌酸显示出比萘啶酸更强的活性,但其活性弱于除卡那霉素外的氨基糖苷类。

相似文献

1
[Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].[近期从临床标本中分离出的铜绿假单胞菌对各种抗菌剂的敏感性以及对羧苄青霉素、庆大霉素和丁胺卡那霉素敏感性的变化(作者译)]
Jpn J Antibiot. 1980 Jun;33(6):668-74.
2
[Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].阿米卡星(BB-K8)与其他氨基糖苷类药物对近期从临床材料中分离出的病原体的抗菌活性比较(作者译)
Jpn J Antibiot. 1975 Aug;28(4):530-7.
3
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.铜绿假单胞菌对四种β-内酰胺抗生素(氨苄西林、头孢噻吩、羧苄西林、哌拉西林)、四种氨基糖苷类抗生素(卡那霉素、阿米卡星、庆大霉素、妥布霉素)以及黏菌素的体外敏感性。
Chemotherapy. 1979;25(1):48-53. doi: 10.1159/000237821.
4
Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.阿米卡星、庆大霉素或妥布霉素与羧苄西林联合使用时对铜绿假单胞菌具有全面且有效的协同作用。
J Int Med Res. 1979;7(5):375-8. doi: 10.1177/030006057900700507.
5
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.新型氨基糖苷类抗生素和羧苄青霉素单独及联合使用时对庆大霉素耐药铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 1976 Sep;10(3):399-401. doi: 10.1128/AAC.10.3.399.
6
[Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas cepacia (author's transl)].
Jpn J Antibiot. 1979 Oct;32(10):998-1002.
7
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.头孢噻肟、头孢磺啶、阿洛西林、美洛西林与氨基糖苷类药物联合应用对耐羧苄西林或敏感铜绿假单胞菌的协同作用。
J Antimicrob Chemother. 1980 Jul;6(4):471-7. doi: 10.1093/jac/6.4.471.
8
Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.耐庆大霉素铜绿假单胞菌的药敏性
Mayo Clin Proc. 1977 Dec;52(12):802-5.
9
Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.新型β-内酰胺类药物与氨基糖苷类药物对铜绿假单胞菌临床分离株的体外活性比较。
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982 Oct;253(1):110-20.
10
Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.妥布霉素、庆大霉素、卡那霉素、黏菌素、羧苄西林和替卡西林对铜绿假单胞菌临床分离株的体外活性比较:流行病学及治疗意义
J Infect Dis. 1976 Aug;134 Suppl:S50-6. doi: 10.1093/infdis/134.supplement_1.s50.